Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Other Operating Expenses (2020 - 2024)

Arcus Biosciences (RCUS) has 7 years of Other Operating Expenses data on record, last reported at $153.0 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses changed N/A year-over-year to $153.0 million; the TTM value through Dec 2025 reached $294.0 million, changed N/A, while the annual FY2025 figure was $523.0 million, 2515.0% up from the prior year.
  • Other Operating Expenses reached $153.0 million in Q4 2025 per RCUS's latest filing, up from $141.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $153.0 million in Q4 2025 and bottomed at $294000.0 in Q3 2022.
  • Average Other Operating Expenses over 3 years is $105.8 million, with a median of $135.0 million recorded in 2024.